Autonomix Medical, Inc. (AMIX)
- Previous Close
1.9000 - Open
1.8100 - Bid 1.8700 x 100
- Ask 1.9900 x 100
- Day's Range
1.8100 - 1.9500 - 52 Week Range
1.5200 - 56.0000 - Volume
175,635 - Avg. Volume
130,919 - Market Cap (intraday)
4.803M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-17.2300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.50
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.
autonomix.comRecent News: AMIX
View MorePerformance Overview: AMIX
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMIX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMIX
View MoreValuation Measures
Market Cap
4.80M
Enterprise Value
-5.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.49
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-97.67%
Return on Equity (ttm)
-662.79%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-13.63M
Diluted EPS (ttm)
-17.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
11.82M
Total Debt/Equity (mrq)
11.66%
Levered Free Cash Flow (ttm)
-4.69M